Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' to the content and included a new Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-03-27T21:59:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision stamp updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T19:35:39.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T14:57:23.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.1 to v3.4.2. No user-facing content or functionality was altered.
    Difference
    0.0%
    Check dated 2026-02-12T15:45:55.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page shows a minor version bump from v3.4.0 to v3.4.1, a routine update with no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T11:21:12.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Show glossary option added and QC-related labels updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The earlier entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-29T03:57:38.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.